Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Coronary Artery Disease Market?

In recent times, there’s been a remarkable growth in the market size of coronary artery disease. Its forecasted expansion from $29.15 billion in 2024 to $31.97 billion in 2025, representing a compound annual growth rate (CAGR) of 9.7%. Factors such as the pervasiveness of coronary artery disease, developments in minimally invasive surgeries, rise in sedentary living, an expanding aging population and the prevalence of CAD, as well as advancements in pharmacological treatments have all contributed to the historical period growth.

What Growth Rate Is Forecasted for the Coronary Artery Disease Market by 2029?

Anticipated to exhibit significant acceleration in the forthcoming years, the market size of coronary artery disease is projected to swell to $48.48 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.0%. The envisaged advancement during this forecast period is linked to various elements such as evolving lifestyle conditions, the emphasis on telemedicine and remote surveillance, enlargement of interventional cardiology methods, transition towards value-inclined healthcare frameworks, and the introduction of groundbreaking drug treatments. Key tendencies anticipated throughout this period involve the evolution of gene therapies, the incorporation of artificial intelligence in diagnosing, prioritizing mental health in CAD care, an upsurge in domestic health care services, and the preference for remote cardiac rehabilitation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

Which Key Companies Are Shaping the Future of the Coronary Artery Disease Market?

Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.

Which Factors Are Driving Demand in the Coronary Artery Disease Industry?

Expectations for the coronary artery disease market to grow in the coming years are largely due to the increasing incidence of the disease. Coronary artery disease (CAD), a medical condition marked by the blockage or narrowing of the coronary arteries supplying blood to the heart muscle, is on the rise because of several factors like changes in diet, stress, lack of physical activity, obesity, aging, among others. The treatment for CAD involves medications such as clopidogrel, ticagrelor, warfarin, and heparin, as well as procedures like coronary artery bypass grafting, angioplasty, and stenting. For instance, statistics from the Centre of Disease Control and Prevention in May 2024 indicate that coronary heart disease (CHD) was the top type of heart disease, resulting in 371,506 deaths in 2022. It also showed that around 5% of adults aged 20 and older (1 in 20) were suffering from coronary artery disease (CAD) with about 1 in 5 cardiovascular disease (CVD) deaths occurring in adults less than 65 years old. Therefore, the increased incidence of coronary artery disease is projected to bolster the growth of the coronary artery disease market during the anticipated period.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp

How Is the Coronary Artery Disease Market Segmented by Several Divisions?

The coronary artery disease market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels

4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors, Other Medications

2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery, Other Surgical Interventions

3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

What are the Emerging Market Trends Driving the Growth of the Coronary Artery Disease Industry?

Leading businesses in the coronary artery disease market are actively working on advancing their technological capabilities, particularly through the integration of AI-based blood tests, in an effort to be more competitive. Such blood tests utilize artificial intelligence (AI) algorithms to analyze and make sense of blood-related information. An example of this can be seen in Cardio Diagnostics Holdings, an American company specializing in AI-based integrated genetic-epigenetic engines, who in February 2023, launched PrecisionCHD. This is a dual genetic and epigenetic blood test, developed to detect coronary heart disease early. PrecisionCHD demonstrates an over 75% sensitivity in identifying coronary heart disease in both genders. To do this, it uses a machine-learning algorithm that has been trained on billions of genomic and epigenomic data points, taking into account epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) markers.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Which Regions Are Driving Growth in the Coronary Artery Disease Market?

North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12052

This Report Delivers Insight On:

1. How big is the coronary artery disease market, and how is it changing globally?

2. Who are the major companies in the coronary artery disease market, and how are they performing?

3. What are the key opportunities and risks in the coronary artery disease market right now?

4. Which products or customer segments are growing the most in the coronary artery disease market?

5. What factors are helping or slowing down the growth of the coronary artery disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model